Elite Graft Program Launched for Wound Care Providers
The new collaboration streamlines biologic graft access and provides protection against Medicare clawback audits.
Updated on Oct. 13, 2026 in Healthcare
Live Poll
Do you believe bundled service programs are a reliable way to manage medical administrative risks?
Shoreline Medical Administration, CHUM Health, and Cellution Biologics have launched the Elite Graft Program to integrate biologic graft access with revenue cycle management. This initiative aims to help wound care providers mitigate financial risks related to clinical outcomes and post-payment audits.
Why it matters
Wound care providers often face significant financial uncertainty from complex reimbursement processes and Medicare audits. The program addresses these vulnerabilities by offering a combined system for documentation review, claims management, and legal defense.
Clinical trials showed that AmchoPlast achieved a 71% complete wound closure rate compared to 23% for standard care. Additionally, usage of the biologic graft resulted in a 78% reduction in wound area.
The players
Shoreline Medical Administration
This organization specializes in clinical documentation review and financial protection services for medical practices.
CHUM Health
The firm manages complex revenue cycle operations including insurance eligibility verification and claims appeals.
Cellution Biologics
This entity develops and manufactures biologic graft products intended for advanced wound care treatment.
The details
The program integrates three distinct services: Cellution Biologics provides the AmchoPlast graft without upfront cost, CHUM Health handles administrative tasks like prior authorizations and coding, and Shoreline Medical Administration conducts documentation reviews. For claims approved by Shoreline, providers receive protection that covers legal defense and potential clawback costs if appeals fail.
Timeline
The Elite Graft Program was officially announced on October 13, 2026.
Market Landscape
This program reflects a growing trend of industry consolidation where specialized services unite to insulate providers from regulatory and audit risks. It positions these companies against fragmented administrative solutions by offering a centralized, turnkey workflow for specialized wound care.
Wound care practices may see reduced administrative burdens and lower financial risks during the Medicare billing process. These changes could potentially streamline patient access to advanced biologic graft treatments without upfront costs.
The takeaway
The program demonstrates how integrating administrative and clinical services can reduce the financial volatility often associated with specialized medical procedures. Providers should evaluate whether this model aligns with their existing billing workflows to potentially decrease audit-related liabilities.
What happens next
Providers interested in the initiative can register for the upcoming webinar titled Beyond the Graft.
Further reading
Learn more about the latest innovations in Healthcare.
More information
Access the Elite Graft Program webinar registration for additional program details.
Live Poll
Do you believe bundled service programs are a reliable way to manage medical administrative risks?
